Showing results (141-150 of 286) with videos related to

Sort By:
Pageof 29
Leukemia|October 1, 2010
Donor-specific differences in long-term outcomes of myeloablative transplantation in adults with Philadelphia-negative acute lymphoblastic leukemiaS Lee, N-G Chung, B-S Cho, et al.
Bone Marrow Transplantation|March 26, 2014
PBSC vs BM grafts with myeloablative conditioning for unrelated donor transplantation in adults with high-risk ALLS-H Shin, J-H Yoon, S-A Yahng, et al.
Bone Marrow Transplantation|August 12, 2014
Identification of molecular and cytogenetic risk factors for unfavorable core-binding factor-positive adult AML with post-remission treatment outcome analysis including transplantationJ-H Yoon, H-J Kim, J-W Kim, et al.
Bone Marrow Transplantation|November 7, 2012
Survival benefits with transplantation in secondary AML evolving from myelodysplastic syndrome with hypomethylating treatment failureS-H Shin, S-A Yahng, J-H Yoon, et al.
Leukemia|June 19, 2012
Impact of minimal residual disease kinetics during imatinib-based treatment on transplantation outcome in Philadelphia chromosome-positive acute lymphoblastic leukemiaS Lee, D-W Kim, B-S Cho, et al.
Diabetologia|October 24, 2012
Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK-SIRT1-PGC1α axis in db/db miceM Y Kim, J H Lim, H H Youn, et al.
Bone Marrow Transplantation|July 30, 2013
Experiences of t-PA use in moderate-to-severe hepatic veno-occlusive disease after hematopoietic SCT: is it still reasonable to use t-PA?J-H Yoon, W-S Min, H-Je Kim, et al.
Bone Marrow Transplantation|September 25, 2012
Risk and prognostic factors for acute GVHD based on NIH consensus criteriaS-E Lee, B-S Cho, J-H Kim, et al.
Oncogene|January 17, 2017
Oncogenic BRAF fusions in mucosal melanomas activate the MAPK pathway and are sensitive to MEK/PI3K inhibition or MEK/CDK4/6 inhibitionH S Kim, M Jung, H N Kang, et al.
Oncogene|April 25, 2012
Identification of a pivotal endocytosis motif in c-Met and selective modulation of HGF-dependent aggressiveness of cancer using the 16-mer endocytic peptideK-W Cho, J H Park, C-W Park, et al.
Pageof 29